Evgen

Evgen synthesizes and commercializes sulforaphane and stabilizes it for pharmaceutical application.

Evgen (www.evgen.com) was founded by serial entrepreneur Dr Stephen Franklin in 2008. The Company is dedicated to commercialising the clinical potential of sulforaphane (and related compounds), a molecule of botanical origin with an exciting and compelling body of scientific literature supporting multiple human healthcare benefits. The Company holds proprietary technology that enables sulforaphane, for the first time, to be synthesised and then subsequently stabilised for pharmaceutical application.